[Form 4] Lennox International Inc. Insider Trading Activity

Rhea-AI Filing Summary

Lennox International insider Chris Kosel, listed as Vice President, Corporate Controller and CAO, reported a sale of 300 shares of Lennox common stock on 08/22/2025 at an average price of $591.8601 per share. After the sale, Mr. Kosel beneficially owned 1,282 shares directly. The Form 4 was signed on behalf of Mr. Kosel by an attorney-in-fact on 08/25/2025.

Insights

Corporate Governance Expert

TL;DR: Routine officer sale; small holding reduction unlikely to change governance or signal material insider shift.

This Form 4 discloses a single open-market sale of 300 shares by a senior finance officer. The reported remaining ownership of 1,282 shares suggests the transaction is a modest liquidity event rather than a significant vote- or control-related move. No related derivative activity or 10b5-1 plan notation appears in the document, and there is no indication of acceleration, option exercise, or other compensatory transactions.

Securities Analyst

TL;DR: Minor divestiture by an insider; not material to company capitalization or immediate investor valuation.

The sale price of $591.8601 per share and the disposition of 300 shares represent a small absolute value relative to Lennox's market cap. The filing provides clear transaction details but no accompanying explanation for the sale. From a market-impact perspective, this single officer sale is unlikely to affect analyst models or valuation metrics given the modest post-transaction shareholding.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kosel Chris

(Last) (First) (Middle)

2140 LAKE PARK BLVD

(Street)

RICHARDSON TX 75080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LENNOX INTERNATIONAL INC [ LII ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP-Corp Controller and CAO

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, Par Value $0.01 Per Share	08/22/2025		S		300	D	$591.8601	1,282	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Monica M. Brown, attorney-in-fact for Mr. Kosel	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Lennox insider Chris Kosel report on Form 4 (LII)?

The Form 4 reports a sale of 300 shares of Lennox common stock on 08/22/2025 at an average price of $591.8601 per share.

How many Lennox (LII) shares does Chris Kosel own after the reported transaction?

After the sale, Mr. Kosel is reported to beneficially own 1,282 shares directly.

What is Chris Kosel's role at Lennox International (LII)?

The filing lists Mr. Kosel as VP - Corporate Controller and CAO and indicates he is an officer of the company.

When was the Form 4 for the Kosel transaction signed and who signed it?

The signature block shows the Form 4 was signed on behalf of Mr. Kosel by Monica M. Brown, attorney-in-fact on 08/25/2025.

Does the Form 4 show any derivative transactions or 10b5-1 plan designation?

No derivative transactions are reported in Table II, and the filing does not indicate a 10b5-1 plan designation.